Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Wellington Management Group LLP reported a 6.50% stake in Dianthus Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 12, 2025
Wellington Management Group LLP reported a 6.50% stake in Dianthus Therapeutics, Inc., 2,577,662 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 2,577,662
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 6.50% | 2,577,662 |
| Wellington Group Holdings LLP | 6.50% | 2,577,662 |
| Wellington Investment Advisors Holdings LLP | 6.50% | 2,577,662 |
| Wellington Management Company LLP | 6.30% | 2,577,662 |
Source
Related
- Dianthus Therapeutics, Inc.
- Wellington Management Group LLP
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026
- Schedule 13G/A · Wellington Management Group LLP · May 15, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026